IP Library Granted Patent US 7,714,131
Granted Patent B2
US 7,714,131 · App. 11/525,200 · Granted May 11, 2010

Process for the stereoselective preparation of (−)-halofenate and derivatives thereof

Assignee: Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,714,131
App. No.
11/525,200
Granted
May 11, 2010
Kind
B2
Abstract

The present invention provides a compounds the formula (IV): and methods for producing an α-(phenoxy)phenylacetic acid compound of the formula: wherein R 1 is a member selected from the group consisting of: each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro; the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d); the subscript m is an integer of from 0 to 3; * indicates a carbon which is enriched in one stereoisomeric configuration; and the wavy line indicates the point of attachment of R 1 ; and compounds.

Claims (73)

1. A method for preparing a compound of formula (I):

wherein

R 1 is a member selected from the group consisting of:

each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro;

the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d);

the subscript m is an integer of from 0 to 3;

* indicates a carbon which is enriched in one stereoisomeric configuration; and

the wavy line indicates the point of attachment of R 1 ;

the method comprising:

(a) contacting a compound of formula (II):

with a carboxylic acid activating reagent selected from the group consisting of thionyl halides, anhydrides and thioester generating reagents; in a compatible solvent;

(b) brominating the product of step (a) with bromine in a compatible solvent;

(c) esterifying the product of step (b) with a chiral alcohol selected from the group consisting of:

in a compatible solvent to stereoselectively produce a compound of formula (I).

2. The method of claim 1 , wherein R 1 is

3. The method of claim 1 , wherein the compound of formula (II) is 4-chlorophenylacetic acid.

4. The method of claim 1 , wherein the carboxylic acid activating reagent is thionyl halide.

5. The method of claim 1 , wherein the carboxylic acid activating reagent is thionyl chloride.

6. The method of claim 1 , wherein bromine is present in a concentration of about at least 1 molar equivalent to the amount of the compound of formula (II).

7. The method of claim 1 , wherein the solvent is a halogenated alkane solvent.

8. The method of claim 1 , wherein the solvent is 1,2-dichloroethane.

9. The method of claim 1 , wherein said brominating is carried out at a temperature of at least about 70° C.

10. The method of claim 1 , further comprising removing excess bromine under reduced pressure before said step (c).

11. The method of claim 1 , wherein the method is conducted in one reaction vessel.

12. The method of claim 1 , wherein only the compound of Formula (I) is isolated.

13. A method for preparing a compound of formula (I):

wherein

R 1 is a member selected from the group consisting of:

each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro;

the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d);

the subscript m is an integer of from 0 to 3;

* indicates a carbon which is enriched in one stereoisomeric configuration; and

the wavy line indicates the point of attachment of R 1 ;

the method comprising esterifying a compound of the formula:

wherein R is a halide, or when combined with the carbonyl to which it is attached is an anhydride or thioester group; in a compatible solvent with a chiral alcohol selected from the group consisting of:

in a compatible solvent to stereoselectively produce a compound of formula (I).

14. A method for preparing (−)-halofenate comprising i) preparing a compound of formula (I):

wherein

R 1 is a member selected from the group consisting of:

each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro;

the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d);

the subscript m is an integer of from 0 to 3;

* indicates a carbon which is enriched in one stereoisomeric configuration; and

the wavy line indicates the point of attachment of R 1 ;

the method comprising:

(a) contacting a compound of formula (II):

with a carboxylic acid activating reagent selected from the group consisting of thionyl halides, anhydrides and thioester generating reagents; in a compatible solvent;

(b) brominating the product of step (a) with bromine in a compatible solvent;

(c) esterifying the product of step (b) with a chiral alcohol selected from the group consisting of:

in a compatible solvent to stereoselectively produce a compound of formula (I); and further converting the product of said step(s) to (−)-halofenate.

15. A method for preparing (−)-halofenate comprising i) preparing a compound of formula (I):

wherein

R 1 is a member selected from the group consisting of:

each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro;

the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d);

the subscript m is an integer of from 0 to 3;

* indicates a carbon which is enriched in one stereoisomeric configuration; and

the wavy line indicates the point of attachment of R 1 ;

the method comprising:

(a) contacting a compound of formula (II):

with a carboxylic acid activating reagent selected from the group consisting of thionyl halides, anhydrides and thioester generating reagents; in a compatible solvent;

(b) brominating the product of step (a) with bromine in a compatible solvent; and further converting the product of said step(s) to (−)-halofenate.

16. A method for preparing (−)-halofenate comprising i) preparing a compound of formula (I):

wherein

R 1 is a member selected from the group consisting of:

each R 2 is a member independently selected from the group consisting of (C 1 -C 4 )alkyl, halo, (C 1 -C 4 )haloalkyl, amino, (C 1 -C 4 )aminoalkyl, amido, (C 1 -C 4 )amidoalkyl, (C 1 -C 4 )sulfonylalkyl, (C 1 -C 4 )sulfamylalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )heteroalkyl, carboxy and nitro;

the subscript n is 1 when R 1 has the formula (a) or (b) and 2 when R 1 has the formula (c) or (d);

the subscript m is an integer of from 0 to 3;

* indicates a carbon which is enriched in one stereoisomeric configuration; and

the wavy line indicates the point of attachment of R 1 ;

the method comprising esterifying a compound of the formula:

wherein R is a halide, or when combined with the carbonyl to which it is attached is an anhydride or thioester group; in a compatible solvent with a chiral alcohol selected from the group consisting of:

in a compatible solvent to stereoselectively produce a compound of formula (I); and further converting the product of said step(s) to (−)-halofenate.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE EFFECTIVE DATE OF THE CHANGE OF NAME PREVIOUSLY RECORDED ON REEL 039072 FRAME 0872. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jul 22, 2016
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 039431/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2016
From: CYMABAY THERAPEUTICS, INC.
To: DIATEX, INC.
Reel/Frame 039045/0152 →
CHANGE OF NAME Recorded Jun 17, 2016
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 039072/0872 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CON Recorded Jul 16, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022973/0618 →
LICENSE Recorded Jun 17, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022835/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2006
From: ZHU, YAN; CHENG, PENG; CHEN, XIN; MA, JINGYUAN; ZHAO, ZUCHUN
To: METABOLEX, INC.
Reel/Frame 018630/0653 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2006
From: ZHU, YAN; CHENG, PENG; CHEN, XIN; MA, JINGYUAN; ZHAO, ZUCHUN
To: METABOLEX, INC.
Reel/Frame 018630/0739 →
Continuity (2)
Provisional Application 6072030000 · Sep 23, 2005
Related Publication 20070072858A1 · Mar 29, 2007